Figure 2).
Survey questions 6 and 7. A “When patients on oral monotherapy are transitioned to prostacyclin therapy do you routinely continue or discontinue the oral agent?” (n=26). B “When patients on oral combination therapy are transitioned to prostacyclin therapy do you routinely continue or discontinue both oral agents?” (n=26)